Product Risk Warning

Investment involves risks, including the loss of principle. Past performance is not indicative of future results. Before investing in below products, investor should refer to the Fund's prospectus for details, including the risk factors. You should not make investment decision based on the information on this material alone. Please note:

ChinaAMC MSCI India ETF

Investment involves risks, including the loss of principle. Past performance is not indicative of future results. Before investing in the ChinaAMC MSCI India ETF (the "Fund"), investor should refer to the Fund's prospectus and respective KFSs for details, including the risk factors. You should not make investment decision based on the information on this material alone. Please note:

• The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the MSCI India Net Total Return (USD) Index (the "Index").
• The Fund is passively managed and falls in the Index may cause falls in the value of the Fund. The Fund is subject to tracking error risk, trading risk with discount or premium and multi-counter risk.
• The Fund majorly invests in equity securities in India and is subject to equity market risk, geographical concentration risk, emerging market risk, risks associated with India and the India equity market such as higher market volatility and potential settlement difficulties etc.
• The Fund is a FPI registered with the SEBI and is subject to risk related to FPI investment restrictions and registration. Taxation of income and capital gains in India is subject to fiscal law of India, and capital gains tax rate varies depending on various factors including holding period of securities. India Rupee is currently not a freely convertible currency and is subject to foreign exchange control policies by the Indian government. Such laws, rules and guidelines on FPI, Indian tax rates and foreign exchange control policies are subject to change.
• The Fund's base currency is USD but its underlying investment may not be denominated in USD, and the Fund has listed units traded in RMB and HKD counters and unlisted classes designated in currencies other than USD, therefore subject to fluctuations in exchange rates.
• Listed and unlisted classes are subject to different pricing and dealing arrangements. NAV per Unit of each class may be different due to different fees and cost.
• Units of listed class are traded in the secondary market on an intraday basis at the prevailing market price, while units of unlisted class are sold through intermediaries based on the dealing day-end NAV. Investors of unlisted class could redeem at NAV while investors of listed class in the secondary market could only sell at the prevailing market price and may have to exit the Fund at a significant discount. Investors of unlisted class may be at an advantage or disadvantage compared to investors of listed class.
• Distributions will be made in the USD only. Unitholders of distributing classes without USD account may have to bear the fees and charges associated with currency conversion.
• The Fund may at its discretion pay distribution out of capital or effectively out of capital. Payment of dividends out of capital or effectively out of capital amounts to a return or withdrawal of part of an investor's original investment or from any capital gains attributable to that original investment. Any distributions may result in an immediate reduction in the NAV per Unit of the Fund.

Important Information about ChinaAMC CSI 300 Index ETF

• The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the CSI 300 Index (the "Index"). The Fund invests in the PRC's securities market through the Manager's RQFII status and the Stock Connect.
• The Fund is subject to concentration risk as a result of tracking the performance of a single geographical region (the PRC) and may likely be more volatile than a broad-based fund.
• The Fund is subject to risks relating to the RQFII regime, such as change of rules and regulations, default in execution or settlement of transaction by a PRC broker or the PRC Custodian and repatriation restrictions.
• The Fund is subject to risks associated with the Stock Connect, such as change of relevant rules and regulations, quota limitations, suspension of the Stock Connect programme.
• Investing in the PRC, involve greater political, tax, economic, foreign exchange, liquidity, legal and regulatory risks.
• If there is a suspension of the inter-counter transfer of units between counters, the unitholders will only be able to trade their units in the relevant counter on the SEHK. The market price on the SEHK of units traded in different counters may deviate significantly due to different factors, as such investors may pay more or receive less when buying units traded in HKD on the SEHK than in respect of units traded in RMB and vice versa.
• As the SSE and the SZSE may be open when units in the Fund are not priced, the value of the securities in Fund's portfolio may change on days when investors will not be able to purchase or sell the Fund's units. Differences in trading hours between the SSE and the SZSE, and the SEHK and A-Shares' trading bands may increase the level of premium/discount of the unit price to its NAV.
• The Fund is denominated in RMB. RMB is currently not freely convertible and is subject to exchange controls and restrictions. A non-RMB based investors in units are exposed to foreign exchange risk.
• The Fund is subject to securities lending transactions risks, including the risk that the borrower may fail to return the securities in a timely manner.
• Payment of dividends out of capital or effectively out of capital amounts to a return or withdrawal of part of an investor's original investment or from any capital gains attributable to that original investment. Any distributions may result in an immediate reduction in the NAV per Unit of the Fund.
• The Fund is subject to tracking error risk.
• The Fund is not "actively managed" and therefore, when there is a decline in the Index, the Fund will also decrease in value.
• Generally, retail investors can only buy or sell units of the Fund on the SEHK. The trading price of the units on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.

Important Information about ChinaAMC MSCI China A 50 Connect ETF

• The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the MSCI China A 50 Connect Index (the "Index").
• The Fund is passively managed. Falls in the Index are expected to result in corresponding falls in the value of the Fund.
• The Fund's investment in equity securities is subject to general market risks, whose value may fluctuate due to various factors.
• The Index is a new index. The Fund may be riskier than those tracking more established indices with longer operating history.
• The Fund is subject to concentration risks in a single geographical region (Mainland China).
• The Fund may be more volatile than a broadly-based fund.
• The Fund is subject to risks associated with the Stock Connect, such as change of relevant rules and regulations, quota limitations, suspension of the Stock Connect programme.
• The Fund is subject to securities lending transactions risks, including the risk that the borrower may fail to return the securities in a timely manner.
• The Fund is denominated in RMB. RMB is currently not freely convertible and is subject to exchange controls and restrictions. Non-RMB based investors in units are exposed to foreign exchange risk.
• As the SSE and the SZSE may be open when units in the Fund are not priced, the value of the securities in Fund's portfolio may change on days when investors will not be able to purchase or sell the Fund's units. Differences in trading hours between the SSE, the SZSE and the SEHK, and A-Shares' trading bands may increase the level of premium/discount of the unit price to its NAV.
• Generally, retail investors can only buy or sell units of the Fund on the SEHK, of which the trading price is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.
• The Fund is subject to tracking error risk.
• If any suspension of the inter-counter transfer of units and/or any limitation on the level of services by brokers and CCASS participants occurs, unitholders will only be able to trade their units in one counter. The market price of units traded in each counter may deviate significantly.
• Unitholders will receive distributions in the RMB only. Unitholder without RMB account may have to bear the fees and charges associated with currency conversion.
• The Fund may at its discretion pay distribution out of capital or effectively out of capital. Payment of dividends out of capital or effectively out of capital amounts to a return or withdrawal of part of an investor's original investment or from any capital gains attributable to that original investment. Any distributions may result in an immediate reduction in the NAV per Unit of the Fund.

Important Information about ChinaAMC Hang Seng Hong Kong Biotech Index ETF

• The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the Hang Seng Hong Kong-Listed Biotech Index (the "Index").
• The Fund is passively managed. Falls in the Index are expected to result in corresponding falls in the value of the Fund.
• The Fund's investment in equity securities is subject to general market risks, whose value may fluctuate due to various factors.
• The Index is a new index. The Fund may be riskier than those tracking more established indices with longer operating history.
• The Fund is subject to concentration risks in biotech companies and in a particular geographical region (i.e. Hong Kong and mainland China). The Fund may be more volatile than a broadly-based fund.
• The Fund is exposed to risks associated with characters of biotech companies, such as pre-revenue, incurrence of net current liabilities, lower liquidity, higher volatility, dependency on intellectual property rights or patents, technological changes, increased regulations and intense competition.
• The Fund is subject to securities lending transactions risks, including the risk that the borrower may fail to return the securities in a timely manner.
• The Fund is subject to tracking error risk.
• If any suspension of the inter-counter transfer of units and/or any limitation on the level of services by brokers and CCASS participants occurs, unitholders will only be able to trade their units in one counter. The market price of units traded in each counter may deviate significantly.
• Unitholders will receive distributions in the HKD only. Non HKD based unitholder may have to bear bank or financial institution fees and charges associated with currency conversion.
• The Fund's base currency is HKD but has units traded in USD. Investors may be subject to additional costs or losses associated with foreign currency fluctuations.
• Generally, retail investors can only buy or sell units of the Fund on the SEHK. The trading price of the units on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.

Important Information about ChinaAMC Hang Seng TECH Index ETF

• The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the Hang Seng Hong Kong-Listed Biotech Index (the "Index").
• The Fund is passively managed. Falls in the Index are expected to result in corresponding falls in the value of the Fund.
• The Fund's investment in equity securities is subject to general market risks, whose value may fluctuate due to various factors.
• The Index is a new index. The Fund may be riskier than those tracking more established indices with longer operating history.
• The Fund is subject to concentration risks in biotech companies and in a particular geographical region (i.e. Hong Kong and mainland China). The Fund may be more volatile than a broadly-based fund.
• The Fund is exposed to risks associated with characters of biotech companies, such as pre-revenue, incurrence of net current liabilities, lower liquidity, higher volatility, dependency on intellectual property rights or patents, technological changes, increased regulations and intense competition.
• The Fund is subject to securities lending transactions risks, including the risk that the borrower may fail to return the securities in a timely manner.
• The Fund is subject to tracking error risk.
• If any suspension of the inter-counter transfer of units and/or any limitation on the level of services by brokers and CCASS participants occurs, unitholders will only be able to trade their units in one counter. The market price of units traded in each counter may deviate significantly.
• Unitholders will receive distributions in the HKD only. Non HKD based unitholder may have to bear bank or financial institution fees and charges associated with currency conversion.
• The Fund's base currency is HKD but has units traded in USD. Investors may be subject to additional costs or losses associated with foreign currency fluctuations.
• Generally, retail investors can only buy or sell units of the Fund on the SEHK. The trading price of the units on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.

Important Information about ChinaAMC HSI ESG ETF

• The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the HSI ESG Enhanced Index (the "Index").
• The Fund is passively managed. Falls in the Index are expected to result in corresponding falls in the value of the Fund.
• The Fund's investment in equity securities is subject to general market risks, whose value may fluctuate due to various factors.
• The Index is a new index. The Fund may be riskier than those tracking more established indices with longer operating history.
• The Fund is subject to concentration risks in a single geographical region (Greater China). The Fund may be more volatile than a broadly-based fund.
• The Fund is subject to risks associated with ESG investing, such as investment performance affected by ESG exclusion criteria, ESG concentration, incomplete and inaccurate ESG data and assessment, lack of standardized ESG taxonomy, etc.
• The Fund is subject to securities lending transactions risks, including the risk that the borrower may fail to return the securities in a timely manner.
• Generally, retail investors can only buy or sell units of the Fund on the SEHK, of which the trading price is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.
• The Fund is subject to tracking error risk.
• If any suspension of the inter-counter transfer of units and/or any limitation on the level of services by brokers and CCASS participants occurs, unitholders will only be able to trade their units in one counter. The market price of units traded in each counter may deviate significantly.
• Unitholders will receive distributions in the HKD only. Unitholder without HKD account may have to bear the fees and charges associated with currency conversion.
• The Fund may at its discretion pay distribution out of capital or effectively out of capital. Payment of dividends out of capital or effectively out of capital amounts to a return or withdrawal of part of an investor's original investment or from any capital gains attributable to that original investment. Any distributions may result in an immediate reduction in the NAV per Unit of the Fund.

Important Information about ChinaAMC NASDAQ 100 ETF

• The Fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the NASDAQ-100 Index. The Fund concentrates its investment in securities listed on the NASDAQ Stock Market and is subject to concentration risk as a result of tracking the performance of markets in a single country (the US) and securities listed on a single exchange (the NASDAQ Stock Market). It is likely to be more volatile than a broad-based fund as it is more susceptible to fluctuations in value resulting from adverse conditions in the US. The value of securities in the Fund's portfolio may change on days when investors will not be able to purchase or sell units of the Fund as the NASDAQ Stock Market will be open when units of the Fund are not priced.
• The units of the Fund may trade at a substantial premium or discount to their NAV.
• The Fund is subject to tracking error risks due to factors such as fees and expenses and the representative sampling strategy that may be adopted by the Manager.
• The Fund's Base Currency is in HKD but has units traded in USD (in addition to HKD). Investors may be subject to additional costs or losses associated with foreign currency fluctuations between the Base Currency and the USD trading currency when trading units in the secondary market.
• If there is a suspension of the inter-counter transfer of units between the counters and/or any limitation on the level of services provided by brokers and CCASS participants, unitholders will only be able to trade their units in one counter, which may inhibit or delay an investor dealing.
• The market price of units traded in each counter may deviate significantly due to different factors such as market liquidity, market supply and demand in each counter and the exchange rate fluctuations between HKD and USD.

Important Information about ChinaAMC MSCI Japan Hedged to USD ETF

• The Fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the MSCI Japan 100% Hedged to USD Index.
• The Fund concentrates its investment in Japanese securities and is subject to concentration risk as a result of tracking the performance of a single country (Japan). It is likely to be more volatile than a broad-based fund as it is more susceptible to fluctuations in value resulting from adverse conditions in Japan.
• The Fund invests in currency forward contracts for hedging purposes. While this approach is designed to minimise the impact of currency fluctuations on the Fund's returns, there are associated risks involved including costs of hedging, derivative and OTC transactions risks.
• The units of the Fund may trade at a substantial premium or discount to their NAV.
• The Fund is subject to tracking error risks due to factors such as fees and expenses, cost of hedging and the representative sampling strategy that may be adopted by the Manager.

Important Information about ChinaAMC Asia High Dividend ETF

• The Fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the NASDAQ Asia ex Japan Dividend Achievers^TM Index.
• The Fund primarily invests in high dividend yield securities in Asia. Such securities are subject to risks that the dividend could be reduced or abolished, or risks that the value of the securities could decline or have lower-than average potential for price appreciation.
• The units of the Fund may trade at a substantial premium or discount to their NAV.
• The Fund is subject to tracking error risks due to factors such as fees and expenses and the representative sampling strategy that may be adopted by the Manager.

Important Information about ChinaAMC MSCI Europe Quality Hedged to USD ETF

• The fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the MSCI Europe Quality 100% Hedged to USD Index.
• The Fund concentrates its investment in European securities and is subject to concentration risk as a result of tracking the performance of a single geographical region (Europe). It is likely to be more volatile than a broad-based fund as it is more susceptible to fluctuations in value resulting from adverse conditions in Europe.
• The Fund invests in currency forward contracts for hedging purposes. While this approach is designed to minimise the impact of currency fluctuations on the Fund's returns, there are associated risks involved including costs of hedging, derivative and OTC transactions risks.
• The value of securities in the Fund's portfolio may change on days when investors will not be able to purchase or sell units of the Fund as European stock exchanges will be open when units of the Fund are not priced.
• The units of the Fund may trade at a substantial premium or discount to their NAV.
• The Fund is subject to tracking error risks due to factors such as fees and expenses, cost of hedging and the representative sampling strategy that may be adopted by the Manager.

Important Information about ChinaAMC Asia USD Investment Grade Bond ETF

• The fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the Bloomberg Asia USD Investment Grade Bond Index. The Fund primarily invests in fixed rate USD-denominated government-related and corporate investment grade bonds of the Asia ex-Japan region. Such investments involve special risks including interest rate risk, over-the-counter market risk, issuer risk, sovereign debt risk and illiquidity of bonds close to maturity risk.
• Investing in emerging markets involves a greater risk of loss than investing in more developed markets due to, among other factors, greater political, tax, economic, foreign exchange, liquidity and regulatory risks.
• The units of the Fund may trade at a substantial premium or discount to their NAV.
• The Fund is subject to tracking error risks due to factors such as fees and expenses, the representative sampling strategy adopted by the Manager and the liquidity of the underlying bonds.
• The Fund's Base Currency is in HKD but has units traded in USD (in addition to HKD). Investors may be subject to additional costs or losses associated with foreign currency fluctuations between the Base Currency and the USD trading currency when trading units in the secondary market.
• If there is a suspension of the inter-counter transfer of units between the counters and/or any limitation on the level of services provided by brokers and CCASS participants, unitholders will only be able to trade their units in one counter, which may inhibit or delay an investor dealing.
• The market price of units traded in each counter may deviate significantly due to different factors such as market liquidity, market supply and demand in each counter and the exchange rate fluctuations between HKD and USD.

Important Information about ChinaAMC RMB Money Market ETF

• The Fund is actively managed. It does not seek to track any index. It may fail to meet its investment objective as a result of the selection of investments.
• The purchase of a Unit in the Fund is not the same as placing funds on deposit with a bank or deposit-taking company. The Fund does not guarantee repayment of principal.
• Investing in Mainland China involves greater political, social, tax, economic, foreign exchange, liquidity, regulatory, custody and high volatility risks.
• The Fund is subject to concentration risk in Greater China and may likely be more volatile than a broad-based fund.
• The Fund is subject to fixed income and debt instruments investment risks, including short-term fixed income and debt instruments risk, credit, counterparty, volatility, liquidity, interest rate, credit rating, credit rating agency, downgrading, valuation, settlement, sovereign debt risks and "Dim Sum" bond market risks.
• Bank deposits are subject to the credit risks of the relevant financial institutions, and may not be protected by any deposit protection schemes in certain regime.
• The Fund is subject to QFI regime related risks, such as change of rules and regulations, QFI revocation/termination, trading prohibitions, limitations on monies repatriation, default by a QFI custodian/broker.
• The Fund is subject to risks associated with Mainland interbank bond market and Bond Connect, such as suspension of trading, regulatory, volatility, liquidity, settlement and counterparty risk.
• Listed and Unlisted Classes are subject to different pricing and dealing arrangements. NAV per Unit of each class may be different due to different fees and cost. Trading hours of SEHK applicable to Listed Class in the secondary market and dealing deadlines in respect of the Listed Class on the primary market or Unlisted Class are also different.
• Units of Listed Class are traded in the secondary market on an intraday basis at the prevailing market price, while Units of Unlisted Class are sold through intermediaries based on the dealing day-end NAV. Investors of Unlisted Class could redeem at NAV while investors of Listed Class in the secondary market could only sell at the prevailing market price and may have to exit the Fund at a significant discount. Investors of Unlisted Class may be at an advantage or disadvantage compared to investors of Listed Class.
• The Fund is denominated in RMB. RMB is currently not freely convertible and is subject to exchange controls and restrictions. A non-RMB based investors are exposed to foreign exchange risk.
• The trading price of the units of Listed Class on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.
• If there is a suspension of the inter-counter transfer of units between counters, investors will only be able to trade their units in the relevant counter. The market price on the SEHK of units traded in each counter may deviate significantly, as such investors may pay more or receive less when buying units traded in RMB on the SEHK than in respect of units traded in HKD and vice versa.

Important Information about ChinaAMC 20+ Year US Treasury Bond ETF

• The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the ICE U.S. Treasury 20+ Year Bond Index (the "Index").
• The Fund is passively managed and falls in the Index may cause falls in the value of the Fund. The Fund is subject to tracking error risk, trading risk with discount or premium and multi-counter risk.
• The Fund majorly invests in US Treasury debt securities with 20+ years remaining term to maturity and is subject to general market risks, concentration risk, credit/counterparty risk, income risk, interest rate risk, sovereign debt risk, valuation risk, credit rating risk and downgrading risk.
• The Fund is subject to securities lending transactions risks, including the risk that the borrower may fail to return the securities in a timely manner.
• The Fund has Listed Units traded in RMB and HKD counters and Unlisted Classes not designated in USD, therefore subject to fluctuations in exchange rates. Investors in Unlisted Hedged Classes bear the associated costs and may be exposed to the risk associated with hedging instruments used.
• Listed and unlisted classes are subject to different pricing and dealing arrangements. NAV per Unit of each class may be different due to different fees and cost.
• Units of listed class are traded in the secondary market on an intraday basis at the prevailing market price, while units of unlisted class are sold through intermediaries based on the dealing day-end NAV. Investors of unlisted class could redeem at NAV while investors of listed class in the secondary market could only sell at the prevailing market price and may have to exit the Fund at a significant discount. Investors of unlisted class may be at an advantage or disadvantage compared to investors of listed class.
• Distributions will be made in the USD only. Unitholder of distributing classes without USD account may have to bear the fees and charges associated with currency conversion.
• The Fund may at its discretion pay distribution out of capital or effectively out of capital. Payment of dividends out of capital or effectively out of capital amounts to a return or withdrawal of part of an investor's original investment or from any capital gains attributable to that original investment. Any distributions may result in an immediate reduction in the NAV per Unit of the Fund.

Important Information about ChinaAMC Bitcoin ETF and ChinaAMC Ether ETF

• Investment involves risks, including the loss of principle. Past performance is not indicative of future results. Before investing in the ChinaAMC Bitcoin ETF or ChinaAMC Ether ETF collectively, the "Fund", investor should refer to the respective Fund's prospectus for details, including the risk factors. You should not make investment decision based on the information on this material alone. Please note:
• ChinaAMC Bitcoin ETF aims to provide investment results that, before fees and expenses, closely correspond to the performance of bitcoin, as measured by the performance of the CME CF Bitcoin Reference Rate (APAC Variant) (the "Index").
• ChinaAMC Ether ETF aims to provide investment results that, before fees and expenses, closely correspond to the performance of ether, as measured by the performance of the CME CF Ether-Dollar Reference Rate (APAC Variant) (the "Index").
• The Fund is passively managed and falls in the Index may cause falls in the value of the Fund. The Fund is subject to new product risk, new index risk, tracking error risk and trading risk with discount or premium.
• Due to the Fund's direct exposure in bitcoin/ether only, it is subject to concentration risk and risks related to bitcoin/ether, such as bitcoin/ether and bitcoin/ether industry risk, speculative nature risk, unforeseeable risks, extreme price volatility risk, concentration of ownership risk, regulatory risk, fraud, market manipulation and security failure risk, cybersecurity risks, potential manipulation of bitcoin network risk, forks risk, risk of illicit use, trading hour difference risk.
• The Fund is subject to risks related to virtual asset trading platform ("VATP"), custody risks and risk relating to the difference between executable price of bitcoin/ether on SFC-licensed VAPTs and Index price for cash subscription and redemption.
• Listed and Unlisted Classes are subject to different pricing and dealing arrangements. NAV per Unit of each class may be different due to different fees and cost. Dealing deadlines of each class are different.
• Units of Listed Class are traded in the secondary market on an intraday basis at the prevailing market price, while Units of Unlisted Class are sold through intermediaries based on the dealing day-end NAV. Investors of Unlisted Class could redeem at NAV while investors of Listed Class in the secondary market could only sell at the prevailing market price and may have to exit the Fund at a significant discount. Investors of Unlisted Class may be at an advantage or disadvantage compared to investors of Listed Class.
• The Fund is subject to multi-counter risks.
• Please note the above list of risks is not exhaustive, please refer to the Fund's prospectus for details.

Important Information about ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product
ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product (the "Product") is a leveraged product. It is different from conventional exchange traded funds as it seeks leveraged investment results relative to NASDAQ-100 Index (the "Index") and only on a daily basis. The Product is not intended for holding longer than one day as the performance of the Product over a longer period may deviate from and be uncorrelated to the leveraged performance of the Index over the period. The Product is designed to be used for short term trading or hedging purposes, and is not intended for long term investment. The Product only targets sophisticated trading-oriented investors who understand the potential consequences of seeking daily leveraged results and the associated risks and constantly monitor the performance of their holdings on a daily basis.

• The Product aims to provide daily investment results, before fees and expenses, which closely correspond to the twice (2x) the daily performance of the Index. The Product does not seek to achieve its stated investment objective over a period of time greater than one day.
• The Product is a derivative product and is not suitable for all investors. There is no guarantee of the repayment of principal. Your investment in the Product may suffer substantial or total losses.
• The Product is not intended for holding longer than one day as the performance of the Product over a period longer than one day will very likely differ in amount and possibly direction from the leveraged performance of the Index over that same period (e.g. the loss may be more than twice the fall in the Index).
• Investment in futures contracts involves specific risks such as high volatility, leverage, rollover and margin risks. There may be imperfect correlation between the value of the underlying reference assets and the futures contracts, which may prevent the Product from achieving its investment objective. The Product may be adversely affected by the cost of rolling positions forward as the futures contracts approach expiry. An extremely high degree of leverage is typical of a futures trading account. As a result, a relatively small price movement in a future contract may result in a proportionally high impact and substantial losses to the Product.
• The Product will use leverage to achieve a Daily return equivalent to twice (2x) of the return of the Index. Should the value of the underlying securities of the Index decrease, the use of a leverage factor of 2 in the Product will trigger an accelerated decrease in the value of the Product's NAV compared to the Index. Both gains and losses will be magnified. Unitholders could, in certain circumstances including a bear market, face minimal or no returns, or may even suffer a complete loss, on such investments.
• There is no assurance that the Product can rebalance its portfolio on a Daily basis to achieve its investment objective. Market disruption, regulatory restrictions or extreme market volatility may adversely affect the Product's ability to rebalance its portfolio.
• The Product is exposed to liquidity risk linked to the futures contracts. Moreover, the rebalancing activities of the Product typically take place at or around the close of trading on the NASDAQ to minimise tracking difference. As a result, the Product may be more exposed to the market conditions during a shorter interval and may be more subject to liquidity risk.
• The Product is normally rebalanced at or around the close of trading on the NASDAQ. As such, return for investors that invest for period less than a full trading day will generally be greater than or less than two times (2x) leveraged investment exposure to the Index, depending upon the movement of the Index from the end of one trading day until the time of purchase.
• Daily rebalancing of Product's holdings causes a higher level of portfolio transactions than compared to the conventional exchange traded funds. High levels of transactions increase brokerage and other transaction costs.
• The Product's investment in equity securities is subject to general market risks.
• The Product is subject to concentration risks as a result of tracking the leveraged performance of companies from the technology sector and its concentration in the US market which may be more volatile than other markets. The value of the Product may be more volatile than that of a broadly-based fund.
• The Product may be subject to tracking error risk. Tracking error may result from the investment strategy used, high portfolio turnover, liquidity of the market and fees and expenses and the correlation between the performance of the Product and the twice (2x) Daily performance of the Index may be reduced. There can be no assurance of exact or identical replication of the twice performance of the Index at any time, including on an intra-day basis.
• Distributions (if any) will be made in USD. If you has no USD account, you may have to bear the fees and charges associated with the conversion of such dividend from USD to HKD or any other currency.
• The Product is passively managed and the Manager will not have the discretion to adapt to market change due to the inherent investment nature of the Product. Falls in the Index are expected to result in falls in the value of the Product.
• The daily price limit for the NASDAQ (which is triggered when the price of the S&P 500 Index drops 20% in a day) and the daily price limit for the futures contracts are different. As such, should the Index's daily price movement be greater than the price limit of the futures contracts, the Product may not be able to achieve its investment objective as the futures contracts are unable to deliver a return beyond their price limit.
• As the CME may be open when Units in the Product are not priced, the value of the futures contracts in the Product's portfolio, or the value of constituents in the Index to which such futures contracts are linked, may change on days when investors will not be able to purchase or sell the Product's Units. Differences in trading hours between the CME and the SEHK may increase the level of premium/discount of the Unit price to its NAV. The NASDAQ and the CME have different trading hours. Trading of the Index constituents closes earlier than trading of the futures contracts, so there may continue to be price movements for the futures contracts when Index constituents are not trading.
• The trading price of the Units on the SEHK is driven by market factors such as the demand and supply of the Units. Therefore, the Units may trade at a substantial premium or discount to the NAV.

Important Information about ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (the "Product") is to provide daily investment results, before fees and expenses, which closely correspond to the two times inverse (-2x) of the Daily performance of the NASDAQ-100 Index (the "Index"). It is different from conventional exchange traded funds. The Product is not intended for holding longer than one day as the performance of the Product over a longer period may deviate from and be uncorrelated to the two times inverse performance of the Index over the period. The Product is designed to be used for short term trading or hedging purposes, and is not intended for long term investment. This Product is a derivative product only targets sophisticated trading-oriented investors who understand the potential consequences of seeking daily two times inverse results and the associated risks and constantly monitor the performance of their holdings on a daily basis.

• The Product will utilise leverage to achieve a Daily return equivalent to minus two times (-2x) the return of the Index. Both gains and losses will be magnified. The risk of loss resulting from an investment in the Product in certain circumstances including a bull market will be substantially more than a fund that does not employ leverage.
• The Product is not intended for holding longer than one day as the performance of the Product over a period longer than one day will very likely differ in amount and possibly direction from the two times inverse performance of the Index over that same period (e.g. the loss may be more than -2 times the increase in the Index).
• Investing in the Product is different from taking a short position. Because of rebalancing, the return profile of the Product is not the same as that of a short position.
• Risk investment outcome of the Product is the opposite of conventional investment funds. If the value of the Index increases for extended periods, the Product will likely to lose most or all of its value.
• Investment in futures contracts involves specific risks such as high volatility, leverage, rollover and margin risks. There may be imperfect correlation between the value of the underlying reference assets and the futures contracts. An extremely high degree of leverage is typical of a futures trading account. As a result, a relatively small price movement in an E-mini NASDAQ 100 Future may result in a proportionally high impact and substantial losses to the Product.
• The Product tracks the two-times inverse (-2x) Daily performance of the Index. Should the value of the underlying securities of the Index increase, it could have a magnified negative effect on the performance of the Product.
• There is no assurance that the Product can rebalance its portfolio on a Daily basis to achieve its investment objective. Market disruption, regulatory restrictions or extreme market volatility may adversely affect the Product's ability to rebalance its portfolio.
• The Product is exposed to liquidity risk linked to E-mini NASDAQ 100 Futures. Moreover, the rebalancing activities of the Product typically take place at or around the close of trading on the NASDAQ to minimise tracking difference.
• The Product is normally rebalanced at or around the close of trading on the NASDAQ. As such, return for investors that invest for period less than a full trading day will generally be greater than or less than the inverse investment exposure to the Index.
• Daily rebalancing of Product's holdings causes a higher level of portfolio transactions than compared to the conventional exchange traded funds. High levels of transactions increase brokerage and other transaction costs.
• The Product is subject to concentration risks as a result of tracking the inverse performance of companies from the technology sector and its concentration in the US market which may be more volatile than other markets. The value of the Product may be more volatile than that of a broadly-based fund.
• The Product may be subject to tracking error risk. Tracking error may result from the investment strategy used, high portfolio turnover, liquidity of the market and fees and expenses and the correlation between the performance of the Product and the two times inverse (-2x) Daily performance of the Index may be reduced. There can be no assurance of exact or identical replication of the two times inverse performance of the Index at any time, including on an intra-day basis.
• Distributions (if any) will be made in USD. If you has no USD account, you may have to bear the fees and charges associated with the conversion of such distribution from USD to HKD or any other currency.
• The Product is passively managed and the Manager will not have the discretion to adapt to market change due to the inherent investment nature of the Product. When the Index moves in an unfavourable direction (i.e. if it increases), the Product will decrease in value.
• The daily price limit for the NASDAQ and the daily price limit for the E-mini NASDAQ 100 Futures are different. As such, should the Index's daily price movement be greater than the price limit of the E-mini NASDAQ 100 Futures, the Product may not be able to achieve its investment objective.
• As the CME may be open when Units in the Product are not priced, the value of the E-mini NASDAQ 100 Futures in the Product's portfolio, or the value of constituents in the Index to which such futures contracts are linked, may change on days when investors will not be able to purchase or sell the Product's Units. Differences in trading hours between the CME and the SEHK may increase the level of premium/discount of the Unit price to its NAV. The NASDAQ and the CME have different trading hours. Trading of the Index constituents closes earlier than trading of the E-mini NASDAQ 100 Futures, so there may continue to be price movements for the E-mini NASDAQ 100 Futures when Index constituents are not trading.
• The trading price of the Units on the SEHK is driven by market factors such as the demand and supply of the Units. Therefore, the Units may trade at a substantial premium or discount to the NAV.